Last reviewed · How we verify

NCT06746974

Comparing the Effects of Extracorporeal Shockwave Therapy and Splinting in the Treatment of Trigger Finger

Not yet recruiting NA Last updated 24 December 2024
What this trial tests

NA trial testing Shockwave in Trigger Finger in 24 participants. Not yet recruiting.

Timeline
15 January 2025
Primary endpoint
30 June 2026
30 November 2026

Quick facts

Lead sponsorMahidol University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment24
Start date15 January 2025
Primary completion30 June 2026
Estimated completion30 November 2026

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

18 and older, any sex, with Trigger Finger or Shockwave Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare the effects of extracorporeal shockwave therapy and splinting in the treatment of trigger finger. Participants will: Be randomized into two groups (shockwave group and splint group). Visit the clinic once a week for four weeks for therapy. Keep a diary of their symptoms, which will be reviewed at six weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Shockwave

Trials testing the same drug.

Other recruiting trials for Trigger Finger

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06746974.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing